In addition, it is known that patients with rheumatoid arthritis (RA) are more sensitive in their NO production system via iNOS and interleukin (IL)-18 [5,6], and are reportedly more susceptible to NSAID-induced GI injuries when compared with other NSAID users [7,8]. The gene discussed is IL18; the disease is rheumatoid arthritis.